MoneyWorks4Me

RPG Life Sciences - Quaterly Results

28 Apr 2025 Evaluate
The March 2025 quarter revenue stood at Rs. 1430.90 millions, up 12.68% as compared to Rs. 1269.90 millions during the corresponding quarter last year.The Net Profit of the company reported a remarkable increase of 786.33% to Rs. 1173.50  millions  from Rs. 132.40 millions in previous same quarter.Operating Profit saw a handsome growth to 305.50 millions from 223.70 millions in the quarter ended March 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 1430.90 1269.90 12.68 6534.30 5820.50 12.26 6534.30 5820.50 12.26
Other Income 50.60 16.50 206.67 126.80 72.10 75.87 126.80 72.10 75.87
PBIDT 305.50 223.70 36.57 1723.30 1353.60 27.31 1723.30 1353.60 27.31
Interest 1.80 1.40 28.57 6.20 4.50 37.78 6.20 4.50 37.78
PBDT 1402.70 222.30 530.99 2543.10 1349.10 88.50 2543.10 1349.10 88.50
Depreciation 53.70 44.90 19.60 214.30 170.70 25.54 214.30 170.70 25.54
PBT 1349.00 177.40 660.43 2328.80 1178.40 97.62 2328.80 1178.40 97.62
TAX 175.50 45.00 290.00 496.40 301.80 64.48 496.40 301.80 64.48
Deferred Tax 0.70 -9.50 -107.37 -0.50 -23.60 -97.88 -0.50 -23.60 -97.88
PAT 1173.50 132.40 786.33 1832.40 876.60 109.03 1832.40 876.60 109.03
Equity 132.30 132.30 0.00 132.30 132.30 0.00 132.30 132.30 0.00
PBIDTM(%) 21.35 17.62 21.20 26.37 23.26 13.40 26.37 23.26 13.40
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..